Introduction
============

Potassium channels are the largest and the most diverse super-family of ion channels in living organisms from bacteria and insects to animals including humans. Among them, Ca^2+^-activated potassium channels (K~Ca~) comprise many members. They are divided into three subfamilies: big (or large) conductance (BK~Ca~, Slo, or K~Ca~1.1, encoded by *KCNMA1*), intermediate conductance (IK~Ca~ or K~Ca~3.1, encoded by *KCNN4*), and small conductance channels (SK~Ca~1, SK~Ca~2, and SK~Ca~3 or K~Ca~2.1, K~Ca~2.2, and K~Ca~2.3, encoded by *KCNN1, KCNN2*, and *KCNN3*, respectively) ([@B13]; [@B15]). The three SK~Ca~ channels are expressed in excitable tissues (e.g., neurons, skeletal muscle, adrenal gland, and heart) and also in some non-excitable tissues (e.g., liver, vascular endothelium, cancers, etc.) ([@B37]). In neurons, apamin-sensitive SK~Ca~ current is responsible for afterhyperpolarization ([@B35]) and regulates firing frequency as well as learning and memory ([@B1]). In the cardiovascular system, SK~Ca~ channels contribute to cardiac repolarization ([@B44]; [@B24]; [@B47]), endothelium-derived hyperpolarization-type arterial dilation in response to increased hemodynamics ([@B43]), and also provide negative feedback on sympathetic tone ([@B32]). Results from recent studies suggest that SK~Ca~ channels play a role in atrial fibrillation (AF) ([@B11]; [@B12]; [@B26]; [@B17]), tumor cell migration and metastasis ([@B6]), and overactive bladder ([@B30]). A recent report demonstrated that the SK~Ca~ inhibitor apamin may cause ventricular arrhythmias in failing rabbit hearts ([@B5]); however, blockade of SK~Ca~ channels is very effective in anti-AF ([@B11]; [@B26]; [@B17]). The development of SK channel blockers has been considered as a new therapeutic strategy in the treatment of AF ([@B46]).

We have previously reported that the natural flavone acacetin from the traditional Chinese medicinal herb Xuelianhua (*Saussurea involucrata*) prolongs the atrial effective refractory period and prevents or terminates the experimentally induced AF in anesthetized dogs without increasing the QT interval ([@B23]; [@B25]) by inhibiting atrial *I*~Kur~ (ultra-rapidly activating delayed rectifier potassium current) or Kv1.5, *I*~K.ACh~ (acetylcholine-activated potassium current), and *I*~to~ (transient outward potassium current) ([@B39], [@B38]). The present study investigated the effects of acacetin on SK~Ca~1, SK~Ca~2, SK~Ca~3, IK~Ca~, and BK~Ca~ currents in HEK 293 cells stably expressing corresponding channel genes with a conventional whole-cell patch voltage-clamp technique. Our results showed that acacetin inhibited the three subtypes of SK~Ca~ channels, but not IK~Ca~ and BK~Ca~ channels, suggesting that the blockade of SK~Ca~ channels may also participate in the anti-AF previously observed in experimental canine models.

Materials and Methods {#s1}
=====================

Cell Line Culture and Gene Transfection
---------------------------------------

The pCDNA3/rSK~Ca~2 (*KCNN2*), pCDNA3/hSK~Ca~3 (*KCNN3*), and pCDNA3/hIK~Ca~ (*KCNN4*) plasmids obtained as generous gifts from Dr. Nicole Schmitt (Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark) were transfected into HEK 293 cells (ATCC, Manassas, VA, United States) using Lipofectamine 2000^TM^. The HEK 293 cell lines stably expressing the SK~Ca~1, SK~Ca~2, and SK~Ca~3 channels were established as described previously ([@B42]). The cell lines were maintained in Dulbecco's modified Eagle's medium (Invitrogen, Hong Kong, China) supplemented with 10% fetal bovine serum and G418 (400 μg/ml). HEK 293 cell line ([@B41]) stably expressing human BK~Ca~ (*KCNMA1*) was also maintained in the same culture conditions. Cells were seeded on glass cover slips for electrophysiological recording.

The primers of SK~Ca~3 mutants were synthesized by the Genome Research Center, the University of Hong Kong (Hong Kong), and the mutants were generated using a QuikChange kit (Stratagene, La Jolla, CA, United States). After confirmed by DNA sequencing, the mutants were transiently expressed in HEK 293 cells in a 35 mm culture dish using Lipofectamine 2000^TM^ (10 μl) with SK~Ca~3 mutant cDNA plasmid (4 μg).

Drugs and Solutions
-------------------

Acacetin (5,7-dihydroxy-4′-methoxyflavone) was synthesized in the laboratory as described previously in the US patent ([@B22]). The stock solution (100 mM) of acacetin was prepared with dimethyl sulfoxide, aliquoted, and stored at -20°C. Tyrode's solution used in this study contained (in mM): 140 NaCl, 5.4 KCl, 1 MgCl~2~, 1.8 CaCl~2~, 10 HEPES, and 10 glucose (pH was adjusted to 7.3 with NaOH). The pipette solution contained (in mM): 20 KCl, 110 potassium aspartate, 1.0 MgCl~2~, 10 HEPES, 5 EGTA, 0.1 GTP, 5 sodium phosphocreatine, and 5 Mg-ATP, pH adjusted to 7.2 with KOH ([@B40]), in which 300 nM free Ca^2+^ (calculated using the Cabuf software provided by Dr. G. Droogmans, Department of Physiology, KU Leuven, Leuven, Belgium) was included.

Electrophysiology
-----------------

The HEK 293 cells on a coverslip were placed into a cell chamber mounted on the stage of an inverted microscope (Olympus, IX70, Japan), and superfused with Tyrode's solution (2 ml/min). Whole-cell current was recorded with a patch clamp amplifier (EPC-10, HEKA Elektronik, Lambrecht, Germany) as described previously ([@B39], [@B42], [@B41]; [@B31]). Briefly, glass electrodes (1.2 mm OD) were pulled with a Brown--Flaming puller (Model P-97, Sutter Instrument Co., Novato, CA, United States). Resistance of the glass pipettes was 2--3 MΩ when filled with the pipette solution. Whole-cell configuration was established by a gentle suction after a gigaohm-seal was obtained. Electrical signal was stored on the hard disk of a PC computer. All experiments were performed at room temperature (22--23°C).

Statistical Analysis
--------------------

The data were expressed as means ± SEM. Unpaired Student's *t*-tests were used as appropriate to evaluate the differences between two group means, and ANOVA was used for multiple groups. A value of *P* \< 0.05 was considered to indicate statistical significance.

Results
=======

Effect of Acacetin on SK~Ca~1 Current
-------------------------------------

The effect of acacetin on SK~Ca~1 current was determined in HEK 293 cells stably expressing human *KCNN1*. **Figure [1A](#F1){ref-type="fig"}** displays the voltage-dependent SK~Ca~1 current recorded with 200-ms voltage steps between -70 and +80 mV from a holding potential of -80 mV in a representative cell. The current was inhibited by 10 μM acacetin (10 min exposure), and the inhibition was partially reversed by washout. **Figure [1B](#F1){ref-type="fig"}** displays the current--voltage (*I--V*) relationships of SK~Ca~1 determined in another typical experiment with a voltage ramp in the absence and presence of acacetin. The *I--V* relationships of SK~Ca~1 current showed a reversal potential around -70 mV and an inward rectification property, typical SK~Ca~ current as described previously ([@B14]; [@B40]). The current was significantly descreased by 10 μM acacetin in bath solution, and the inhibition was partially reversed on washout. **Figure [1C](#F1){ref-type="fig"}** illustrates the concentration-dependent inhibition of SK~Ca~1 current (at +80 mV) by acacetin. The concentration--response curve was fitted to a Hill equation to obtain IC~50~ (the concentration of inhibiting 50% current) value. The IC~50~ of acacetin for inhibiting SK~Ca~1 at +80 mV was 12.4 μM (Hill co-efficient, 0.8).

![Effect of acacetin on SK~Ca~1 channel stably expressed in HEK 293 cells. **(A)** SK~Ca~1 current was activated in a representative cell expressing human *KCNN1* by 200-ms step voltages between --70 and +80 mV from a holding potential of --80 mV in the absence and presence of 10 μM acacetin. **(B)** Current--voltage (*I--V*) relationships of SK~Ca~1 current were recorded in a typical experiment with a 3-s voltage ramp from --100 to +80 mV in the absence and presence of 10 μM acacetin. **(C)** Concentration--response relationship of acacetin for inhibiting SK~Ca~1 current (+80 mV) was fitted to a Hill equation to obtain IC~50~ value of acacetin.](fphar-08-00716-g001){#F1}

Effect of Acacetin on SK~Ca~2 Current
-------------------------------------

The effect of acacetin on SK~Ca~2 current was determined in HEK 293 cell line expressing rat *KCNN2*. **Figure [2A](#F2){ref-type="fig"}** shows the voltage-dependent SK~Ca~2 current in a typical experiment with the voltage protocol as shown in the inset. The current was significantly decreased by 10 μM acacetin (10 min exposure) at all testing potentials, and the inhibition was partially reversed by washout. *I--V* relationships of SK~Ca~2 current determined by a ramp voltage protocol also showed an inward rectification. Inward and outward components of the current were decreased by 10 μM acacetin, and the inhibition was partially recovered on drug washout (**Figure [2B](#F2){ref-type="fig"}**). **Figure [2C](#F2){ref-type="fig"}** illustrates the concentration--response relationship of acacetin for inhibiting SK~Ca~2 current (at +80 mV). The curve was fitted to a Hill equation. The IC~50~ of acacetin for inhibiting SK~Ca~2 current was 10.8 μM (Hill coefficient, 0.8).

![Effect of acacetin on SK~Ca~2 channel stably expressed in HEK 293 cells. **(A)** SK~Ca~2 current was activated in a representative cell expressing rat *KCNN2* by 200-ms step voltages between --70 and +80 mV from a holding potential of --80 mV in the absence and presence of 10 μM acacetin. **(B)** Current--voltage (*I--V*) relationships of SK~Ca~2 current were recorded in a typical experiment with a 3-s voltage ramp from --100 to +80 mV in the absence and presence of 10 μM acacetin. **(C)** Concentration--response relationship of acacetin for inhibiting SK~Ca~2 current (+80 mV) was fitted to a Hill equation to obtain IC~50~ value of acacetin.](fphar-08-00716-g002){#F2}

Inhibition of SK~Ca~3 Current by Acacetin
-----------------------------------------

The inhibitory effect of acacetin on SK~Ca~3 was determined in HEK 293 cell line expressing human *KCNN3* gene. The voltage-dependent step SK~Ca~3 current was determined with the voltage protocol as shown in the inset in a typical experiment (**Figure [3A](#F3){ref-type="fig"}**). SK~Ca~3 current at all test potentials was inhibited by 10 μM acacetin with 10 min incubation, and the inhibition partially recovered on washout for 10 min. *I--V* relationships of SK~Ca~3 current was determined with a ramp voltage protocol in another cell (**Figure [3B](#F3){ref-type="fig"}**) before and after application of acacetin. The current also displays an inward rectification and was reversibly decreased by 10 μM acacetin. The concentration--response curve of acacetin for inhibiting SK~Ca~ 3 current was fitted to a Hill equation (**Figure [3C](#F3){ref-type="fig"}**). The IC~50~ of acacetin for inhibiting SK~Ca~3 was 11.6 μM (with a Hill coefficient of 0.8).

![Effect of acacetin on SK~Ca~3 channel stably expressed in HEK 293 cells. **(A)** SK~Ca~3 current was activated in a representative cell expressing human *KCNN3* by 200-ms step voltages between --70 and +80 mV from a holding potential of --80 mV in the absence and presence of 10 μM acacetin. **(B)** Current--voltage (*I--V*) relationships of SK~Ca~3 current were recorded in a typical experiment with a 3-s voltage ramp from --100 to +80 mV in the absence and presence of 10 μM acacetin. **(C)** Concentration--response relationship of acacetin for inhibiting SK~Ca~3 current (+80 mV) was fitted to a Hill equation to obtain IC~50~ value of acacetin.](fphar-08-00716-g003){#F3}

Molecular Determinant of Acacetin for Inhibiting SK~Ca~ Channels
----------------------------------------------------------------

The potential molecular determinant of acacetin for inhibiting SK~Ca~ channels was investigated using SK~Ca~3 mutants, H490N, S512T, H521N, and A537V in P-loop helix and S6, generated by site-directed mutagenesis as described previously ([@B38],[@B40]). **Figure [4A](#F4){ref-type="fig"}** illustrates the *I--V* relationships of wild type (WT) SK~Ca~ current and mutant currents recorded in representative cells expressing WT SK~Ca~3 or the mutant H490N, S512T, or H521N with a voltage ramp protocol before (control) and after 10 μM acacetin. The inhibitory effect of acacetin for the mutant H490N and S512T currents was clearly reduced, compared with WT SK~Ca~3 current. **Figure [4B](#F4){ref-type="fig"}** illustrates the percent values of current inhibition by 10 μM acacetin for WT SK~Ca~3, and the mutants H490N, S512T, H521N, and A537V currents at +80 mV. Acacetin at 10 μM decreased the current by 45.7 ± 4.1% for WT SK~Ca~1 current (*n* = 11), 21.9 ± 4.5% for H490N current (*n* = 7, *P* \< 0.01 vs. WT), 17.9 ± 3.9% for S512T current (*n* = 7, *P* \< 0.01 vs. WT), 48.8 ± 3.5% for H521N current (*n* = 7, *P* \> 0.05 vs. WT), and 40.8 ± 7.6% for A537V current (*n* = 6, *P* \> 0.05 vs. WT), respectively.

![Effect of acacetin on WT and mutant SK~Ca~3 channel currents expressed in HEK 293 cells. **(A)** Current--voltage (*I--V*) relationships of SK~Ca~3 WT current, H490N, S512T, H521N were recorded in typical experiments with a 3-s voltage ramp from --100 to +80 mV in the absence and presence of 10 μM acacetin. **(B)** Percent values of 10 μM acacetin for inhibiting SK~Ca~3 WT current (*n* = 11, H490N current (*n* = 7, ^∗∗^*P* \< 0.01 vs. WT), S512T current (*n* = 7, ^∗∗^*P* \< 0.01 vs. WT), H521N current (*n* = 7, *P* \> 0.05 vs. WT), or A537V current (*n* = 6) at +80 mV.](fphar-08-00716-g004){#F4}

**Figure [5A](#F5){ref-type="fig"}** displays the concentration--response relationships of acacetin for inhibiting WT SK~Ca~3 current, H490N current, S512T current, H521N current, and A537V current at +80 mV. The concentration-dependent inhibition curves were fitted to a Hill equation. The IC~50~ of acacetin was 11.6 μM for WT SK~Ca~3 current, 118.5 μM for H490N current, 275.2 μM for S512T current, 15.3 μM for H521N current, and 10.6 μM for A537V current, respectively. The efficacy of acacetin for inhibiting H490N current and S512T current was dramatically reduced, which suggests that acacetin blocks SK~Ca~3 channel by interacting with H490 and S512 in the P-loop helix of the channel (**Figure [5B](#F5){ref-type="fig"}**).

![IC~50~ values of acacetin for inhibiting SK~Ca~3 WT, H490N, S512T, H521N, or 537V current in HEK 293 cells. **(A)** Concentration--response relationship curves of acacetin for inhibiting SK~Ca~3 WT current (+80 mV), H490N, S512T, H521N, or 537V (*n* = 6--9 for each concentration) was fitted to a Hill equation to obtain IC~50~ values of acacetin. **(B)** Schematic graph showing the putative binding sites of acacetin at H490, S512, and also H521 in the P-loop helix of human SK~Ca~3 channels.](fphar-08-00716-g005){#F5}

Effect of Acacetin on IK~Ca~ Current
------------------------------------

The potential effect of acacetin on IK~Ca~ was determined in HEK 293 cell line expressing human *KCNN4*. The voltage-dependent IK~Ca~ current (**Figure [6A](#F6){ref-type="fig"}**) was recorded with the step voltages as shown in the inset in a typical experiment before and after application of acacetin. Acacetin (10 and 30 μM) slightly decreased the current, and the inhibition was partially recovered on washout. Similar results were observed for the *I--V* relationships of the current recorded with a voltage ramp in another representative cell (**Figure [6B](#F6){ref-type="fig"}**). IK~Ca~ shows a linear *I--V* relationship, similar to those previously recorded in HEK 293 cell line expressing IK~Ca~ ([@B14]). **Figure [6C](#F6){ref-type="fig"}** shows that acacetin (10 and 30 μM) decreased IK~Ca~ (+70 mV) to 95.0 ± 4.5% (*n* = 7, *P* \> 0.05) and 89.3 ± 5.5% of control (*n* = 7, *P* \< 0.05 vs. control, 0 μM), respectively. These results suggest that acacetin has a slight inhibition of IK~Ca~ current.

![Effect of acacetin on IK~Ca~ channel stably expressed in HEK 293 cells. **(A)** IK~Ca~ current was activated in a representative cell expressing human *KCNN4* by 200-ms step voltages between --70 and +70 mV from a holding potential of --80 mV in the absence and presence of 10 or 30 μM acacetin. **(B)** Current--voltage (*I--V*) relationships of IK~Ca~ current were recorded in a typical experiment with a 3-s voltage ramp from --90 to +70 mV in the absence and presence of 10 and 30 μM acacetin. **(C)** Percent values of acacetin (10 or 30 μM) for inhibiting IK~Ca~ current (+70 mV, *n* = 7, ^∗^*P* \< 0.05 vs. 0 μM acacetin).](fphar-08-00716-g006){#F6}

Effect of Acacetin on BK~Ca~ Current
------------------------------------

The effect of acacetin on BK~Ca~ current was examined in HEK 293 cell line expressing human *KCNMA1* gene. Voltage-dependent BK~Ca~ current was recorded with the step voltage protocol as shown in the inset in a representative cell before and after application of acacetin (**Figure [7A](#F7){ref-type="fig"}**). Acacetin had no effect on BK~Ca~ at 3 and 10 μM, whereas it slightly increased the current at 30 μM. *I--V* relationships (**Figure [7B](#F7){ref-type="fig"}**) of BK~Ca~ current determined with a voltage ramp showed a similar response to acacetin. Acacetin did not affect the current at 10 μM, but slightly increased the outward component of BK~Ca~ current at 30 μM. The BK~Ca~ inhibitor paxilline (1 μM) almost fully suppressed the current. The percent values of BK~Ca~ current at +70 mV illustrated in **Figure [7C](#F7){ref-type="fig"}** show that no significant effect of acacetin was observed at 3 and 10 μM, whereas 30 μM acacetin increased the current to 108.1 ± 5.7% of control (*n* = 7, *P* \< 0.05 vs. control). These results suggest that acacetin may stimulate BK~Ca~ channel at high concentration of 30 μM.

![Effect of acacetin on BK~Ca~ channel stably expressed in HEK 293 cells. **(A)** BK~Ca~ current was activated in a representative cell expressing human *KCNMA1* by 200-ms step voltages between --70 and +70 mV from a holding potential of --80 mV in the absence and presence of 3, 10, or 30 μM acacetin. **(B)** Current--voltage (*I--V*) relationships of SK~Ca~3 current were recorded in a typical experiment with a 3-s voltage ramp from --90 to +70 mV in the absence and presence of 10 and 30 μM acacetin. **(C)** Percent values of acacetin (3, 10, or 30 μM) for increasing BK~Ca~ current (+70 mV, *n* = 7, ^∗^*P* \< 0.05 vs. 0 μM acacetin).](fphar-08-00716-g007){#F7}

Discussion
==========

The present study provides the novel information that the natural flavone acacetin blocks the three SK~Ca~ channel subtypes: SK~Ca~1, SK~Ca~2, and SK~Ca~3, stably expressed in HEK 293 cells with similar efficacy. The IC~50~ values of acacetin for inhibiting SK~Ca~1, SK~Ca~2, and SK~Ca~3 are 12.4, 10.8, and 11.6 μM, respectively. Point mutagenesis of SK~Ca~3 channel reveals that acacetin mainly interacts with H490 and S512 in the P-loop helix of the channel. However, acacetin at a high concentration of 30 μM induces only a small decrease in IK~Ca~ channel and a small increase in BK~Ca~ channel stably expressed in HEK 293 cells. The very limited effect of acacetin on IK~Ca~ channel is similar to that reported previously for other SK~Ca~ channel blockers ([@B14]).

An earlier study demonstrated that SK~Ca~ channels were expressed in rat skeletal muscles, and sensitive to blocking by apamin ([@B2]). Then, the sequence of the transmembrane segments of SK~Ca~1, SK~Ca~2, and SK~Ca~3 are found 80--90% identical ([@B21]). However, the three subunits have different sensitivity to blocking by apamin (SK~Ca~2 \> SK~Ca~1 \> SK~Ca~3), and are highly conserved among mammalian species, and are identified in many organisms from *Drosophila* to humans ([@B1]). SK~Ca~ subunits assemble to form homomeric ([@B21]) or heteromeric ([@B33]) tetramers. SK~Ca~ channels are identified in human and mouse atrial myocytes ([@B34]; [@B29]), neurons ([@B8]), and tumor cells ([@B14], [@B13]; [@B15]).

In the heart, activation of SK~Ca~ channel may be antiarrhythmic or proarrhythmic, depending on the myocardial pathophysiological conditions ([@B4]). [@B7] reported that the SK~Ca~ channel current was heterogeneously upregulated in failing rabbit ventricles and SK~Ca~ blocker apamin suppressed post-shock shortening of action potential duration in the failing hearts with ventricular fibrillation. On the other hand, apamin induced ventricular arrhythmias in slowly paced failing rabbit ventricles ([@B5]). The proarrhythmic effect was also observed with apamin in isolated normal canine left atrium ([@B18]).

However, the results from other groups demonstrated that blockade of SK~Ca~ channels prolongs atrial effective refractory period, and SK~Ca~ channels are therefore considered as a promising therapeutic target in the treatment of AF ([@B11], [@B10]; [@B26]; [@B17]). Several SK~Ca~ channel blockers, e.g., NS8593, UCL1684, *N*-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (ICA) and apamin, have been used for anti-AF studies ([@B11], [@B10], [@B9]). In perfused guinea pig hearts, NS8593, UCL1684, and ICA effectively terminated AF induced with a combination of acetylcholine with electric stimulation ([@B11]). Injection of NS8593, UCL1684 or apamin reduced the duration of pacing-induced AF *in vivo* rat model ([@B28]). UCL1684 and NS8593 had significant anti-AF effect in a rat paroxysmal AF with hypertension-induced atrial remodeling ([@B10]). Interestingly, in large animals such as dogs ([@B26]) and horses ([@B17]), intravenous administration of NS8593 terminated all induced AF episodes, increased atrial effective refractory period, and decreased AF duration and vulnerability without QTc interval prolongation, suggesting that SK~Ca~ channel blockers can be considered as promising anti-AF drugs. Moreover, recent studies showed that acute myocardial infarction might activate SK~Ca~ channels, and apamin, UCL-1684 or ICA reduced ventricular burden arrhythmia by prolonging ventricular action potential duration and effective refractory period in rats with acute myocardial infarction ([@B16]; [@B19]).

In this study, we demonstrated that acacetin inhibited SK~Ca~1, SK~Ca~2, and SK~Ca~3 channels in HEK 293 cell line expressing the corresponding genes. The blockade of SK~Ca~ channels by acacetin likely also contributes to the anti-AF effect observed in canine models in addition to blocking *I*~Kur~/Kv1.5, *I*~to~/Kv4.3, and *I*~K.ACh~ ([@B23]; [@B39], [@B38]). These studies suggest that acacetin blocks multiple atrial-selective channels, and would be more effective in anti-AF than the blocker that specifically inhibits one type of atrial channel. However, whether acacetin, as apamin and other SK~Ca~ blockers, is effective in improving learning and memory ([@B1]) remains to be studied in the future. Moreover, additional studies are required for clarifying whether the SK~Ca~ blocking effect of acacetin is related to its anti-cancer effect ([@B27]; [@B45]).

In our previous reports, we demonstrated that acacetin blocked Kv1.5 channel by binding to both its resting and open states by interacting with V505, I508, and V512 within the S6 domain ([@B39]), and inhibited the closed channel and blocked the open state of Kv4.3 by binding to both P-loop selectivity filter and S6 domain ([@B38]). In the present study, we found that H490 and S512, but not H521, of P-loop helix are the binding sites of acacetin for blocking SK~Ca~3 channel. The pore blocking of SK~Ca~3 by acacetin is applicable to SK~Ca~1 and SK~Ca~2, because SK~Ca~1, SK~Ca~2, and SK~Ca~3 share the same sequence in the range of pore helix^[1](#fn01){ref-type="fn"}^. This differs from the molecular determinants of acacetin for blocking Kv1.5 or Kv4.3 channel. On the other hand, the acacetin blockade of SK~Ca~3 channel is different from the organic SK~Ca~ blocker NS8593 and the archetypical peptide SK~Ca~ blocker apamin. NS8593 interacts with S507 of P-loop helix and A532 of S6 domain ([@B20]), while apamin binds to a residue of S3--S4 extracellular loop of outside pore of the channel to produce a high-sensitivity block without selectivity filter contact ([@B36]). While the binding sites of various SK~Ca~ blockers differ, it is important to develop these potential blockers into feasible drug candidates for future clinical application. A water soluble prodrug of acacetin has been developed, which can be intravenously administered for future clinical application ([@B25]).

Acacetin showed increased BK~Ca~ current at concentration of 30 μM. Although the concentration for activating BK~Ca~ channel is greater than those of blocking *I*~Kur~/Kv1.5, *I*~K.ACh~, *I*~to~/Kv4.3, and also SK~Ca~ channels; this effect may account in part for the vascular dilation reported in a previous study ([@B3]).

A limitation of the present study was that all the experiments were conducted only in HEK 293 line expressing SK~Ca~1, SK~Ca~2, or SK~Ca~3 channels and lack of data from native cardiomyocytes. However, this does not affect the conclusion that acacetin blocks SK~Ca~ channels. Future effort is required to obtain the data for the effect of acacetin on SK~Ca~ current in native cardiomyocytes from an animal species whose heart has no or less expression of *I*~Kur~/Kv1.5 and *I*~to~/Kv4.3, because acacetin also inhibits these currents in native human atrial myocytes ([@B23]).

Collectively, the present study demonstrates for the first time that acacetin is a SK~Ca~ channel blocker and inhibits three subtypes of the SK~Ca~ channels stably expressed in HEK 293 cells. The SK~Ca~ channel blocking effect may be involved in its anti-AF property previously observed in experimentally induced AF in dogs.
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